跳至主要内容
临床试验/NCT05498311
NCT05498311招募中2 期

Cosmetic Outcomes Following Conservative Surgery (With or Without Oncoplastic Surgery) for Breast Cancer With Intraoperative Radiotherapy (INTRABEAM) Followed by Hypofractionated External Beam Radiotherapy: a Phase II Trial

Institut Català d'Oncologia2 个研究点 分布在 1 个国家目标入组 89 人开始时间: 2016年10月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
89
试验地点
2
主要终点
Changes in Cosmetic results - BCCT

研究概览

简要总结

To evaluate cosmetic outcomes after conservative surgery for breast cancer with INTRABEAM followed by hypofractionated external beam radiotherapy

详细描述

To evaluate cosmetic outcomes following conservative surgery (with or without oncoplastic surgery) for breast cancer with intraoperative radiotherapy (INTRABEAM) followed by hypofractionated external beam radiotherapy

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Histologically-confirmed diagnosis of invasive breast carcinoma and eligibility for conservative surgery (with or without oncoplastic surgery) and radiotherapy.
  • Not pregnant at diagnosis.
  • Signed informed consent form.
  • Age ≥45 years old.
  • Patients candidates to Intrabeam.
  • Patients with ≥60 years with the presence of one or more of the following adverse criteria after surgery:
  • Tumor size > 2.5 cm.
  • Extensive intraductal carcinoma (≥25%)
  • Lymphovascular invasion.
  • Involved focal margins (<2mm) without ampliation surgery.

排除标准

  • Presence of distant metastasis.
  • Primary chemotherapy.
  • Lymph node involvement.
  • Negative hormonal receptors.
  • Diagnosis of any other infiltrating tumour except for adequately resected squamous or basal cell epitheliomas
  • Patients with collagen vascular disease (systemic lupus erythematosus, scleroderma, dermatomyositis).
  • Uncontrolled infection.
  • Concurrent treatment with other experimental treatments
  • Lack of signed informed consent form.

结局指标

主要结局

Changes in Cosmetic results - BCCT

时间窗: Baseline and every 12 months until 60 months

It will be measured by the BCCT.core software programme. This software uses 4 photographies of the breast for each timepoint and evaluates cosmetic outcome based upon symmetry, skin colour changes and surgical scar appearance. The lower the calculated score, the better the cosmetic outcome (1=excellent, 2=good, 3=fair, 4=poor)

Changes in Cosmetic results - Self Evaluation using YBT

时间窗: Baseline and every 12 months until 60 months

Questionnaire for cosmetic self-evaluation from the Young Boost Trial (YBT) that consists s of 8 questions about various aspects (size, shape, skin colour, massiveness of the breast, nipple position, general appearance, visibility of the surgical scar, and overall satisfaction) to evaluate the degree of satisfaction of the patients themselves about the cosmetic results.

次要结局

  • Changes in Quality of life (QOL) - General(Baseline and every 12 months until 60 months)
  • Changes in Quality of life (QOL) - Breast(Baseline and every 12 months until 60 months)
  • Toxicity (acute and late)(Baseline and every 12 months until 60 months)
  • Local control(Baseline and every 3 months after completion of EBRT and thereafter every 6 months for 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验